IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC), an international medical cannabis company with operations in Israel and Germany, has announced its board of directors’ approval for a consolidation of its issued and outstanding common shares. The consolidation will convert every six pre-consolidated common shares into one post-consolidated share.
IM Cannabis Share Consolidation Date Set
The effective date for this consolidation is set for July 12, 2024. On this date, the common shares are expected to begin trading on a post-consolidated basis, pending final confirmation from the Canadian Securities Exchange and NASDAQ. The company’s name and stock symbols will remain unchanged, although the CUSIP and ISIN numbers will be updated to 44969Q406 and CA44969Q4060, respectively.